13F filer · CIK 1344551 ↗
Assetmark, Inc
You are looking at Q4 2024. See the latest, Q3 2026 →
Reported value
$36.81B
+5.4% on the quarter before
Positions
2,590
441 new · 105 sold out
Top 10
29.8%
of the value
Est. gain
−$32.8M
on stocks held all quarter
Est. return
−0.1%
on those stocks since Q3 2024
Positions as of Dec 31, 2024, from Assetmark, Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.
Largest buys
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- AT&T~$221.3MAdded · 0.0% → 0.6%+9,719,036 shares
- Ishares Tr~$161.9MAdded · 0.5% → 0.9%+1,975,432 shares
- Ishares Tr~$146.8MAdded · 0.0% → 0.4%+1,378,094 shares
- Vanguard Index Fds~$97.2MAdded · 0.0% → 0.3%+335,425 shares
- Ishares Tr~$90.8MAdded · 0.9% → 1.1%+1,805,202 shares
- SPDR Ser Tr~$89.6MAdded · 0.0% → 0.2%+678,191 shares
- Ishares Tr~$86.7MNew · 0.0% → 0.2%+1,069,789 shares
- Nvidia~$84.2MAdded · 1.7% → 2.0%+626,664 shares
- Ingredion Inc~$69.9MAdded · 0.0% → 0.2%+508,027 shares
- Ishares Tr~$68.7MAdded · 1.2% → 1.3%+2,990,094 shares
Largest sells
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$361.1MCut · 1.3% → 0.1%−4,135,453 shares
- Gilead Sciences Inc~$173.7MCut · 0.5% → 0.1%−1,880,494 shares
- SPDR Ser Tr~$107.0MCut · 0.3% → 0.0%−777,119 shares
- Vanguard Scottsdale Fds~$82.5MCut · 0.3% → 0.0%−1,103,828 shares
- Ishares Tr~$72.4MCut · 0.9% → 0.6%−677,465 shares
- SPDR Ser Tr~$53.0MCut · 0.2% → 0.0%−588,528 shares
- Vertex Pharmaceuticals Inc~$50.0MCut · 0.3% → 0.1%−124,206 shares
- SPDR Ser Tr~$48.1MCut · 0.5% → 0.3%−617,553 shares
- Unum Group~$45.4MCut · 0.1% → 0.0%−622,267 shares
- Select Sector SPDR Tr~$41.4MCut · 0.3% → 0.1%−301,077 shares
Holdings
As of Dec 31, 2024. Changes are in shares against Sep 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard World FdMEGA GRWTH IND · shares +0.07% · price +19.2% | 7.0% | $2.56B | +$412.0M | ||||||||
| Vanguard World FdMEGA CAP VAL ETF · shares +2.6% · price −2.6% | 4.9% | $1.79B | −$47.1M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares −0.4% · price +2.1% | 4.6% | $1.69B | +$35.0M | ||||||||
| Vanguard Index FdsSM CP VAL ETF · shares +4.7% · price −1.3% | 2.2% | $792.4M | −$9.9M | ||||||||
| NvidiaCOM · shares +13% · price +10.6% | 2.0% | $741.5M | +$62.9M | ||||||||
| Pimco ETF TrENHAN SHRT MA AC · shares +7.3% · price −0.3% | 2.0% | $721.4M | −$2.3M | ||||||||
| Ishares TrCORE S&P500 ETF · shares +1.2% · price +2.1% | 1.9% | $702.9M | +$14.0M | ||||||||
| MicrosoftCOM · shares +6.7% · price −2.0% | 1.9% | $701.2M | −$13.7M | ||||||||
| AppleCOM · shares +0.9% · price +7.5% | 1.8% | $647.2M | +$44.6M | ||||||||
| Vanguard Index FdsMCAP VL IDXVIP · shares +7.6% · price −3.5% | 1.7% | $635.9M | −$21.6M | ||||||||
| Vanguard Index FdsMCAP GR IDXVIP · shares +4.7% · price +4.2% | 1.6% | $580.6M | +$22.5M | ||||||||
| Ishares TrIBOXX HI YD ETF · shares +2.6% · price −2.1% | 1.6% | $574.1M | −$11.7M | ||||||||
| Ishares TrCORE MSCI EAFE · shares −2.8% · price −10.0% | 1.4% | $517.0M | −$57.2M | ||||||||
| Ishares TrUS TREAS BD ETF · shares +16% · price −2.0% | 1.3% | $492.0M | −$8.7M | ||||||||
| SPDR Ser TrBLOOMBERG HIGH Y · shares +12% · price −2.4% | 1.3% | $473.9M | −$10.3M | ||||||||
| Ishares IncCORE MSCI EMKT · shares +2.9% · price −9.0% | 1.3% | $468.3M | −$45.2M | ||||||||
| MetaCL A · shares +12% · price +2.3% | 1.3% | $461.5M | +$9.2M | ||||||||
| AlphabetCAP STK CL A · shares +3.2% · price +14.1% | 1.2% | $435.4M | +$52.2M | ||||||||
| Vanguard Index FdsSML CP GRW ETF · shares +3.6% · price +4.7% | 1.1% | $408.6M | +$17.9M | ||||||||
| Ishares TrUSD INV GRDE ETF · shares +30% · price −4.4% | 1.1% | $391.7M | −$13.8M | ||||||||
| BroadcomCOM · shares +2.9% · price +34.4% | 1.1% | $391.1M | +$97.3M | ||||||||
| AmazonCOM · shares +13% · price +17.7% | 1.0% | $369.0M | +$49.1M | ||||||||
| Vanguard Scottsdale FdsMTG-BKD SECS ETF · shares +6.2% · price −4.0% | 1.00% | $368.0M | −$14.3M | ||||||||
| Ishares TrMSCI USA MMENTM · shares +3.4% · price +2.1% | 0.98% | $362.3M | +$7.0M | ||||||||
| Ishares Tr0-5YR HI YL CP · shares +7.2% · price −1.9% | 0.96% | $353.2M | −$6.3M | ||||||||
| Total · 2,590 positions | 100% | $36.81B | −$32.8M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2024 to Q4 2024: 2,144 stocks held throughout, down $32.8M (−0.1%).
- Vanguard World Fd+$412.0M+19%
- Broadcom+$97.3M+34%
- Nvidia+$62.9M+11%
- Alphabet+$52.2M+14%
- Amazon+$49.1M+18%
- Regeneron Pharmaceuticals−$34.2M−32%
- Builders Firstsource Inc−$44.3M−26%
- Ishares Inc−$45.2M−9%
- Vanguard World Fd−$47.1M−3%
- Ishares Tr−$57.2M−10%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 13 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $59.48B+2% | SEC ↗ |
| Q2 2026 | Jul 30, 2026 | $58.17B+19% | SEC ↗ |
| Q1 2026 | May 6, 2026 | $49.04B+0% | SEC ↗ |
| Q4 2025 | Jan 23, 2026 | $49.04B+5% | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | $46.65B+10% | SEC ↗ |
| Q2 2025 | Aug 4, 2025 | $42.36B+16% | SEC ↗ |
| Q1 2025 | May 6, 2025 | $36.41B−1% | SEC ↗ |
| Q4 2024 | Feb 6, 2025 | $36.81B+5% | SEC ↗ |
| Q3 2024 | Nov 1, 2024 | $34.92B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $32.33B+5% | SEC ↗ |
| Q1 2024 | May 7, 2024 | $30.76B+11% | SEC ↗ |
| Q4 2023 | Feb 9, 2024 | $27.67B+11% | SEC ↗ |
| Q3 2023 | Oct 27, 2023 | $25.01B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $25.49B+5% | SEC ↗ |
| Q1 2023 | May 5, 2023 | $24.19B+5% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $23.07B+8% | SEC ↗ |
| Q3 2022 | Nov 1, 2022 | $21.39B−4% | SEC ↗ |
| Q2 2022 | Aug 3, 2022 | $22.31B−7% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $23.89B−2% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $24.34B+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $22.32B+4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $21.56B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $19.39B+8% | SEC ↗ |
| Q4 2020 | Feb 10, 2021 | $17.95B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $15.50B+11% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $13.98B+18% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $11.81B−10% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $13.16B+10% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $11.95B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $12.27B+11% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $11.07B+7% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $10.36B−6% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $11.00B+8% | SEC ↗ |
| Q2 2018 | Aug 1, 2018 | $10.18B+5% | SEC ↗ |
| Q1 2018 | May 16, 2018 | $9.66B−0% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $9.70B+10% | SEC ↗ |
| Q3 2017 | Nov 8, 2017 | $8.79B+11% | SEC ↗ |
| Q2 2017 | Aug 15, 2017 | $7.95B+4% | SEC ↗ |
| Q1 2017 | Sep 15, 2017 (amended) | $7.61B+12% | SEC ↗ |
| Q4 2016 | Sep 15, 2017 (amended) | $6.81B+4% | SEC ↗ |
| Q3 2016 | Sep 15, 2017 (amended) | $6.58B+11% | SEC ↗ |
| Q2 2016 | Sep 15, 2017 (amended) | $5.95B+4% | SEC ↗ |
| Q1 2016 | Sep 15, 2017 (amended) | $5.73B | SEC ↗ |